PSUSA/00000576/202412

PSUSA/00002947/202412

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): NexoBrid, concentrate of proteolytic enzymes enriched in bromelain, Date of authorisation: 18/12/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 17, Status: Authorised

EudraVigilance: electronic reporting

Compliance notifications explanation and Q&A